[1]Arris,ChristineE.;Boyle,F.Thomas;Calvert,A.Hilary;Curtin,NicolaJ.;Endicott,JaneA.;Garman,ElspethF.;Gibson,AshleighE.;Golding,BernardT.;Grant,Sharon;Griffin,RogerJ.;Jewsbury,Philip;Johnson,LouiseN.;Lawrie,AlisonM.;Newell,DavidR.;Noble,MartinE.M.;Sausville,EdwardA.;Schultz,Robert;Yu,Wyatt[JournalofMedicinalChemistry,2000,vol.43,#15,p.2797-2804]
[2]CurrentPatentAssignee:CANCERRESEARCHUK-US6677345,2004,B1Locationinpatent:Page/Pagecolumn9-10
[3]Kidwai,Saqib;Bouzeyen,Rania;Chakraborti,Sohini;Khare,Neha;Das,Sumana;Gosain,TannuPriya;Behura,Assirbad;Meena,ChhuttanLal;Dhiman,Rohan;Essafi,Makram;Bajaj,Avinash;Saini,DeepakKumar;Srinivasan,Narayanaswamy;Mahajan,Dinesh;Singh,Ramandeep[AntimicrobialAgentsandChemotherapy,2019,vol.63,#9]
[4]Mesguiche,Veronique;Parsons,RachelJ;Arris,ChristineE;Bentley,Johanne;Boyle,FThomas;Curtin,NicolaJ;Davies,ThomasG;Endicott,JaneA;Gibson,AshleighE;Golding,BernardT;Griffin,RogerJ;Jewsbury,Philip;Johnson,LouiseN;Newell,DavidR;Noble,MartinEM;Wang,LanZ;Hardcastle,IanR[Bioorganicandmedicinalchemistryletters,2003,vol.13,#2,p.217-222]
[1]Mesguiche,Veronique;Parsons,RachelJ;Arris,ChristineE;Bentley,Johanne;Boyle,FThomas;Curtin,NicolaJ;Davies,ThomasG;Endicott,JaneA;Gibson,AshleighE;Golding,BernardT;Griffin,RogerJ;Jewsbury,Philip;Johnson,LouiseN;Newell,DavidR;Noble,MartinEM;Wang,LanZ;Hardcastle,IanR[Bioorganicandmedicinalchemistryletters,2003,vol.13,#2,p.217-222]
[1]Mesguiche,Veronique;Parsons,RachelJ;Arris,ChristineE;Bentley,Johanne;Boyle,FThomas;Curtin,NicolaJ;Davies,ThomasG;Endicott,JaneA;Gibson,AshleighE;Golding,BernardT;Griffin,RogerJ;Jewsbury,Philip;Johnson,LouiseN;Newell,DavidR;Noble,MartinEM;Wang,LanZ;Hardcastle,IanR[Bioorganicandmedicinalchemistryletters,2003,vol.13,#2,p.217-222]
[1]Mesguiche,Veronique;Parsons,RachelJ;Arris,ChristineE;Bentley,Johanne;Boyle,FThomas;Curtin,NicolaJ;Davies,ThomasG;Endicott,JaneA;Gibson,AshleighE;Golding,BernardT;Griffin,RogerJ;Jewsbury,Philip;Johnson,LouiseN;Newell,DavidR;Noble,MartinEM;Wang,LanZ;Hardcastle,IanR[Bioorganicandmedicinalchemistryletters,2003,vol.13,#2,p.217-222]
[1]Bioorganicandmedicinalchemistryletters,2003,vol.13,p.217-222
[2]JournalofMedicinalChemistry,2000,vol.43,p.2797-2804
Title: Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms.
Journal: Oncotarget 20150922
Title: Trovafloxacin-induced replication stress sensitizes HepG2 cells to tumor necrosis factor-alpha-induced cytotoxicity mediated by extracellular signal-regulated kinase and ataxia telangiectasia and Rad3-related.
Journal: Toxicology 20150504
Title: Trovafloxacin enhances lipopolysaccharide-stimulated production of tumor necrosis factor-α by macrophages: role of the DNA damage response.
Journal: The Journal of pharmacology and experimental therapeutics 20140701
Title: Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family.
Journal: Bioorganic & medicinal chemistry letters 20120901
Title: A modular approach to trim cellular targets in anticancer drug discovery.
Journal: Bioorganic & medicinal chemistry letters 20111115
Title: Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines.
Journal: British journal of cancer 20110726
Title: Novel structural features of CDK inhibition revealed by an ab initio computational method combined with dynamic simulations.
Journal: Journal of medicinal chemistry 20060824
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: 4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2.
Journal: Bioorganic & medicinal chemistry letters 20030120
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry 20020419
